What does RTI stand for?

Reverse Transcriptase Inhibitor

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Reprographic Technologies, Inc. (Milwaukee, WI) Request To Import (shipping industry) Research Tactical Idea (Morgan Stanley) Research Technologies International (Lincolnwood, Illinois) Research Triangle Institute Residency Training Initiative Respiratory Tract Infection Response Time Index (fire sprinklers) Response to Intervention (education) Return from Interrupt (assembly language)		Right to Information Act (India) RightNow Technologies, Inc. (software; Bozeman, MT) Road and Traffic Information (Volvo) Road Traffic Incident Roadway Type Identifier Rockwool Technical Insulation (Netherlands) Romanticism through Impressionism (course) Roof Tile Institute Route Index Run Time Interconnect

Samples in periodicals archive:

Intelence is a non-nucleoside reverse transcriptase inhibitor, or NNRTI, that blocks the enzyme HIV needs to multiply.

J&J warns of allergic reactions with HIV drug

Efavirenz is an antiviral agent in the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) class.

FDA Notifications

Intelence is a non-nucleoside reverse transcriptase inhibitor, or NNRTI, that blocks the enzyme HIV needs to multiply.

J&J seeks full FDA approval for HIV treatment

A single dose of tenofovir and emtricitabine at delivery reduced resistance to nonnucleoside reverse transcriptase inhibitors at 6 weeks after delivery by half.

A single dose of tenofovir and emtricitabine can reduce resistance

Non-nucleoside reverse transcriptase inhibitor (NNRTI) HIV treatment regimens are better at suppressing the virus than protease inhibitor (PI) regimens.

Non-nucleoside reverse transcriptase inhibitor (NNRTI) HIV treatment ...

1588296490 Reverse transcriptase inhibitors in AIDS therapy.

Reverse Transcriptase Inhibitors in AIDS Therapy

Sustiva is a nonnucleoside reverse transcriptase inhibitor and Emtriva and Viread are nucleoside reverse transcriptase inhibitors.

Once-a-day combination pill approved for HIV

Ed4T, which was developed by Yale University, Kagoshima University and Showa University, is a nucleoside reverse transcriptase inhibitor with enhanced anti-HIV-1 activity.

Oncolys Biopharma, Yale University Conclude Licensing Agreement in ...